UBS Group Lowers McKesson (NYSE:MCK) Price Target to $1,000.00

McKesson (NYSE:MCK) had its price target cut by UBS Group from $1,012.00 to $1,000.00 in a research note issued on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group’s price target suggests a potential upside of 20.64% from the company’s current price.

A number of other brokerages have also weighed in on MCK. Morgan Stanley reiterated an “overweight” rating and issued a $966.00 price target on shares of McKesson in a report on Thursday, January 29th. TD Cowen lifted their price target on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Weiss Ratings lowered shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. Barclays raised their target price on shares of McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a research note on Wednesday, February 18th. Finally, Robert W. Baird set a $968.00 target price on shares of McKesson in a research note on Wednesday, January 14th. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $972.27.

McKesson Trading Down 1.6%

Shares of MCK traded down $13.31 during mid-day trading on Wednesday, reaching $828.94. The company had a trading volume of 1,117,866 shares, compared to its average volume of 754,535. The stock has a market cap of $101.54 billion, a price-to-earnings ratio of 23.84, a price-to-earnings-growth ratio of 1.24 and a beta of 0.42. The firm has a fifty day simple moving average of $910.28 and a 200-day simple moving average of $856.99. McKesson has a fifty-two week low of $637.00 and a fifty-two week high of $999.00.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. The company had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. McKesson’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter last year, the business earned $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, equities analysts predict that McKesson will post 39.02 EPS for the current fiscal year.

Insider Buying and Selling at McKesson

In other news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Michele Lau sold 2,725 shares of the firm’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the transaction, the executive vice president directly owned 3,247 shares in the company, valued at approximately $3,214,530. This represents a 45.63% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 3,592 shares of company stock worth $3,518,555. 0.08% of the stock is currently owned by insiders.

Institutional Investors Weigh In On McKesson

Large investors have recently added to or reduced their stakes in the company. University of Texas Texas AM Investment Management Co. acquired a new stake in McKesson during the 4th quarter valued at $25,000. Swiss RE Ltd. acquired a new stake in McKesson during the 4th quarter valued at $26,000. GGM Financials LLC acquired a new stake in McKesson during the 3rd quarter valued at $25,000. State of Wyoming acquired a new stake in McKesson during the 2nd quarter valued at $29,000. Finally, Hopwood Financial Services Inc. acquired a new stake in McKesson during the 3rd quarter valued at $31,000. 85.07% of the stock is owned by institutional investors and hedge funds.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.